These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29675452)

  • 1. Attaching-and-Effacing Pathogens Exploit Junction Regulatory Activities of N-WASP and SNX9 to Disrupt the Intestinal Barrier.
    Garber JJ; Mallick EM; Scanlon KM; Turner JR; Donnenberg MS; Leong JM; Snapper SB
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):273-288. PubMed ID: 29675452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nck adaptors, besides promoting N-WASP mediated actin-nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector.
    Nieto-Pelegrin E; Kenny B; Martinez-Quiles N
    Cell Adh Migr; 2014; 8(4):404-17. PubMed ID: 25482634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteropathogenic
    Tapia R; Kralicek SE; Hecht GA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability.
    Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F
    Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clever Cooperation: Interactions Between EspF and Host Proteins.
    Hua Y; Yan K; Wan C
    Front Microbiol; 2018; 9():2831. PubMed ID: 30524410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tight junctions and enteropathogenic E. coli.
    Weflen AW; Alto NM; Hecht GA
    Ann N Y Acad Sci; 2009 May; 1165():169-74. PubMed ID: 19538303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals.
    Xia X; Liu Y; Hodgson A; Xu D; Guo W; Yu H; She W; Zhou C; Lan L; Fu K; Vallance BA; Wan F
    PLoS Pathog; 2019 Jun; 15(6):e1007898. PubMed ID: 31251784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterohemorrhagic E. coli requires N-WASP for efficient type III translocation but not for EspFU-mediated actin pedestal formation.
    Vingadassalom D; Campellone KG; Brady MJ; Skehan B; Battle SE; Robbins D; Kapoor A; Hecht G; Snapper SB; Leong JM
    PLoS Pathog; 2010 Aug; 6(8):e1001056. PubMed ID: 20808845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive N-WASP-binding elements of the enterohemorrhagic Escherichia coli effector EspF(U) synergistically activate actin assembly.
    Campellone KG; Cheng HC; Robbins D; Siripala AD; McGhie EJ; Hayward RD; Welch MD; Rosen MK; Koronakis V; Leong JM
    PLoS Pathog; 2008 Oct; 4(10):e1000191. PubMed ID: 18974829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the role of the Tir:Nck and Tir:IRTKS/IRSp53 signalling pathways in vivo.
    Crepin VF; Girard F; Schüller S; Phillips AD; Mousnier A; Frankel G
    Mol Microbiol; 2010 Jan; 75(2):308-23. PubMed ID: 19889090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
    Tapia R; Kralicek SE; Hecht GA
    Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.
    Viswanathan VK; Koutsouris A; Lukic S; Pilkinton M; Simonovic I; Simonovic M; Hecht G
    Infect Immun; 2004 Jun; 72(6):3218-27. PubMed ID: 15155623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.
    McNamara BP; Koutsouris A; O'Connell CB; Nougayréde JP; Donnenberg MS; Hecht G
    J Clin Invest; 2001 Mar; 107(5):621-9. PubMed ID: 11238563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways.
    Alto NM; Weflen AW; Rardin MJ; Yarar D; Lazar CS; Tonikian R; Koller A; Taylor SS; Boone C; Sidhu SS; Schmid SL; Hecht GA; Dixon JE
    J Cell Biol; 2007 Sep; 178(7):1265-78. PubMed ID: 17893247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models.
    Schüller S; Chong Y; Lewin J; Kenny B; Frankel G; Phillips AD
    Cell Microbiol; 2007 May; 9(5):1352-64. PubMed ID: 17474908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E. coli secreted protein F promotes EPEC invasion of intestinal epithelial cells via an SNX9-dependent mechanism.
    Weflen AW; Alto NM; Viswanathan VK; Hecht G
    Cell Microbiol; 2010 Jul; 12(7):919-29. PubMed ID: 20088948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated transient interaction of ZO-1 and afadin is required for pedestal maturation induced by EspF from enteropathogenic Escherichia coli.
    Ugalde-Silva P; Navarro-Garcia F
    Microbiologyopen; 2019 Dec; 8(12):e931. PubMed ID: 31568664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo.
    Shifflett DE; Clayburgh DR; Koutsouris A; Turner JR; Hecht GA
    Lab Invest; 2005 Oct; 85(10):1308-24. PubMed ID: 16127426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attaching and effacing pathogen-induced tight junction disruption in vivo.
    Guttman JA; Li Y; Wickham ME; Deng W; Vogl AW; Finlay BB
    Cell Microbiol; 2006 Apr; 8(4):634-45. PubMed ID: 16548889
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Karjalainen M; Hellman M; Tossavainen H; Permi P
    Biomol NMR Assign; 2021 Apr; 15(1):213-217. PubMed ID: 33475933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.